Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
56
ARS.CX Quote, Financials, Valuation and Earnings
Last price:
$0.50
Seasonality move
:
1.42%
Day range:
$0.48 - $0.54
52-week range:
$0.15 - $1.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.73x
Volume:
393.6K
Avg. volume:
838K
1-year change:
241.38%
Market cap:
$116.3M
Revenue:
--
EPS (TTM):
-$0.03
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $29.3K | $40.7K | $41.1K | $39.9K | $275.1K | |
| Gross Profit | -$29.3K | -$40.7K | -$41.1K | -$39.9K | -$275.1K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.6M | $4.3M | $3.5M | $3.2M | $4.9M | |
| Other Inc / (Exp) | -$44.4K | -$678.4K | -$1.2M | $78.8K | -- | |
| Operating Expenses | $3.6M | $4.2M | $2.8M | $1.1M | $3M | |
| Operating Income | -$3.6M | -$4.3M | -$2.8M | -$1.2M | -$3.3M | |
| Net Interest Expenses | $5K | $5.7K | $612.7K | $2M | $1.7M | |
| EBT. Incl. Unusual Items | -$3.7M | -$5M | -$4.7M | -$2.9M | -$3.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$235.4K | -- | -- | |
| Net Income to Company | -$3.7M | -$5M | -$4.4M | -$2.9M | -$3.6M | |
| Minority Interest in Earnings | $900 | -$1.9K | $1.8K | $3.4K | $2K | |
| Net Income to Common Excl Extra Items | -$3.7M | -$5M | -$4.4M | -$2.9M | -$3.6M | |
| Basic EPS (Cont. Ops) | -$0.04 | -$0.04 | -$0.03 | -$0.02 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.04 | -$0.04 | -$0.03 | -$0.02 | -$0.02 | |
| Weighted Average Basic Share | $94.3M | $126.1M | $138.3M | $150.5M | $190.5M | |
| Weighted Average Diluted Share | $94.3M | $126.1M | $138.3M | $150.5M | $190.5M | |
| EBITDA | -$3.6M | -$4.2M | -$2.8M | -$1.1M | -$3M | |
| EBIT | -$3.6M | -$4.3M | -$2.8M | -$1.2M | -$3.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.6M | -$4.3M | -$2.8M | -$1.2M | -$3.3M | |
| Operating Income (Adjusted) | -$3.6M | -$4.3M | -$2.8M | -$1.2M | -$3.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.9K | $10.9K | $10.3K | $9.5K | $252.7K | |
| Gross Profit | -$9.9K | -$10.9K | -$10.3K | -$9.5K | -$252.7K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $553K | $2.6M | $579.8K | $679.6K | $2.5M | |
| Other Inc / (Exp) | $28.8K | -$226.7K | -$105.9K | -$26.4K | -- | |
| Operating Expenses | $543.1K | $2.6M | $141.1K | $504.2K | $1.2M | |
| Operating Income | -$553K | -$2.7M | -$151.4K | -$513.7K | -$1.5M | |
| Net Interest Expenses | $1K | -- | $414K | $103K | $1.2M | |
| EBT. Incl. Unusual Items | -$525.1K | -$2.8M | -$671.3K | -$616.1K | -$1.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$235.4K | -- | -- | |
| Net Income to Company | -$525.1K | -$2.8M | -$435.9K | -$616.1K | -$1.9M | |
| Minority Interest in Earnings | -$1K | -$1.3K | -$2.4K | $5.3K | $800 | |
| Net Income to Common Excl Extra Items | -$525.1K | -$2.8M | -$435.9K | -$616.1K | -$1.9M | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.00 | -$0.00 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.00 | -$0.00 | -$0.01 | |
| Weighted Average Basic Share | $106.8M | $137.8M | $139M | $173.4M | $211.6M | |
| Weighted Average Diluted Share | $106.8M | $137.8M | $139M | $173.4M | $211.6M | |
| EBITDA | -$543.1K | -$2.6M | -$141.1K | -$504.2K | -$1.2M | |
| EBIT | -$553K | -$2.7M | -$151.4K | -$513.7K | -$1.5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$553K | -$2.7M | -$151.4K | -$513.7K | -$1.5M | |
| Operating Income (Adjusted) | -$553K | -$2.7M | -$151.4K | -$513.7K | -$1.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $29.3K | $40.7K | $41.1K | $39.9K | $275.1K | |
| Gross Profit | -$29.3K | -$40.7K | -$41.1K | -$39.9K | -$275.1K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $926.4K | $4.3M | $3.5M | $3.2M | $5.9M | |
| Other Inc / (Exp) | -$44.4K | -$678.4K | -$2.5M | $595K | -- | |
| Operating Expenses | $3.6M | $4.1M | $2.8M | $1.1M | $3M | |
| Operating Income | -$3.6M | -$4.2M | -$2.8M | -$1.2M | -$3.3M | |
| Net Interest Expenses | $5.1K | $76.4K | $613K | $2M | $2.7M | |
| EBT. Incl. Unusual Items | -$3.7M | -$5M | -$4.7M | -$2.4M | -$4.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$235.4K | -- | -- | |
| Net Income to Company | -$3.7M | -$5M | -$4.4M | -$2.9M | -$3.6M | |
| Minority Interest in Earnings | $900 | -$1.9K | $1.8K | $3.4K | $2K | |
| Net Income to Common Excl Extra Items | -$3.7M | -$5M | -$4.5M | -$2.4M | -$4.7M | |
| Basic EPS (Cont. Ops) | -$0.04 | -$0.04 | -$0.03 | -$0.02 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.04 | -$0.04 | -$0.03 | -$0.02 | -$0.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$3.6M | -$4.1M | -$2.8M | -$1.1M | -$3M | |
| EBIT | -$3.6M | -$4.2M | -$2.8M | -$1.2M | -$3.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.6M | -$4.2M | -$2.8M | -$1.2M | -$3.3M | |
| Operating Income (Adjusted) | -$3.6M | -$4.2M | -$2.8M | -$1.2M | -$3.3M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $40.7K | $41.1K | $40K | $275.1K | -- | |
| Gross Profit | -$40.7K | -$41.1K | -$40K | -$275.1K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.3M | $3.5M | $3.2M | $5.9M | -- | |
| Other Inc / (Exp) | -$678.4K | -$2.5M | $595K | $450.4K | -- | |
| Operating Expenses | $4.1M | $2.8M | $1.1M | $3M | -- | |
| Operating Income | -$4.2M | -$2.8M | -$1.2M | -$3.3M | -- | |
| Net Interest Expenses | $76.4K | $613K | $2M | $2.7M | -- | |
| EBT. Incl. Unusual Items | -$5M | -$4.7M | -$2.4M | -$4.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$235.4K | -- | -- | -- | |
| Net Income to Company | -$5M | -$4.4M | -$2.9M | -$3.6M | -- | |
| Minority Interest in Earnings | -$1.9K | $1.7K | $3.3K | $2K | -- | |
| Net Income to Common Excl Extra Items | -$5M | -$4.5M | -$2.4M | -$4.7M | -- | |
| Basic EPS (Cont. Ops) | -$0.04 | -$0.03 | -$0.02 | -$0.02 | -- | |
| Diluted EPS (Cont. Ops) | -$0.04 | -$0.03 | -$0.02 | -$0.02 | -- | |
| Weighted Average Basic Share | $504.9M | $553.3M | $633.6M | $765.3M | -- | |
| Weighted Average Diluted Share | $504.9M | $553.3M | $633.6M | $765.3M | -- | |
| EBITDA | -$4.1M | -$2.8M | -$1.1M | -$3M | -- | |
| EBIT | -$4.2M | -$2.8M | -$1.2M | -$3.3M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$4.2M | -$2.8M | -$1.2M | -$3.3M | -- | |
| Operating Income (Adjusted) | -$4.2M | -$2.8M | -$1.2M | -$3.3M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1M | $520.1K | $1.8M | $2.2M | $8M | |
| Short Term Investments | -- | $386K | $170.9K | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $234.5K | -- | -- | -- | -- | |
| Other Current Assets | -- | $251K | $290.4K | $646K | -- | |
| Total Current Assets | $1.4M | $1.3M | $2.1M | $3.4M | $10.8M | |
| Property Plant And Equipment | $3.8M | $5.3M | $7.3M | $15.9M | $33.8M | |
| Long-Term Investments | -- | -- | -- | $393.7K | $333.6K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $94.7K | $101.6K | $101K | $276.1K | -- | |
| Total Assets | $13.4M | $16.1M | $17.5M | $36.5M | $53.9M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $922.5K | $296.5K | $1.9M | $9M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.6M | $1.1M | $2.6M | $12.8M | $11.7M | |
| Long-Term Debt | -- | -- | $4.7M | $11.1M | $26.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.6M | $1.1M | $7.3M | $23.9M | $37.8M | |
| Common Stock | $31.4M | $39.3M | $39.6M | $44.4M | $51.5M | |
| Other Common Equity Adj | -$45.7K | $78.1K | $139.2K | $158.4K | -- | |
| Common Equity | $12M | $16.3M | $11.4M | $13.8M | $17.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1.2M | -$1.2M | -$1.2M | -$1.2M | -$1.2M | |
| Total Equity | $10.8M | $15.1M | $10.2M | $12.6M | $16M | |
| Total Liabilities and Equity | $13.4M | $16.1M | $17.5M | $36.5M | $53.9M | |
| Cash and Short Terms | $1.1M | $520.1K | $1.8M | $2.2M | $8M | |
| Total Debt | -- | -- | $5.5M | $18.3M | $34.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1M | $520.1K | $1.8M | $2.2M | $8M | |
| Short Term Investments | -- | $386K | $170.9K | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $234.5K | -- | -- | -- | -- | |
| Other Current Assets | -- | $251K | $290.4K | $646K | -- | |
| Total Current Assets | $1.4M | $1.3M | $2.1M | $3.4M | $10.8M | |
| Property Plant And Equipment | $3.8M | $5.3M | $7.3M | $15.9M | $33.8M | |
| Long-Term Investments | -- | -- | -- | $393.7K | $333.6K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $94.7K | $101.6K | $101K | $276.1K | -- | |
| Total Assets | $13.4M | $16.1M | $17.5M | $36.5M | $53.9M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $922.5K | $296.5K | $1.9M | $9M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.6M | $1.1M | $2.6M | $12.8M | $11.7M | |
| Long-Term Debt | -- | -- | $4.7M | $11.1M | $26.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.6M | $1.1M | $7.3M | $23.9M | $37.8M | |
| Common Stock | $31.4M | $39.3M | $39.6M | $44.4M | $51.5M | |
| Other Common Equity Adj | -$45.7K | $78.1K | $139.2K | $158.4K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$1.2M | -$1.2M | -$1.2M | -$1.2M | -$1.2M | |
| Total Equity | $10.8M | $15.1M | $10.2M | $12.6M | $16M | |
| Total Liabilities and Equity | $13.4M | $16.1M | $17.5M | $36.5M | $53.9M | |
| Cash and Short Terms | $1.1M | $520.1K | $1.8M | $2.2M | $8M | |
| Total Debt | -- | -- | $5.5M | $18.3M | $34.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.7M | -$5M | -$4.4M | -$2.9M | -$3.6M | |
| Depreciation & Amoritzation | $29.3K | $40.7K | $41.1K | $39.9K | $275.1K | |
| Stock-Based Compensation | $1.5M | $2M | $1.3M | -- | -- | |
| Change in Accounts Receivable | -$30.5K | $5.8K | $16.2K | -$32.9K | -$47.1K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.8M | -$1.8M | -$1.7M | $405.5K | -$1.9M | |
| Capital Expenditures | $2.3M | $3.2M | $3.6M | $16M | $10M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.3M | -$3.1M | -$3.5M | -$16M | -$10M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $20K | $236.5K | $6.2M | $14.1M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $553K | -- | $521.7K | -$688K | -- | |
| Cash From Financing | $5.1M | $3.8M | $6.8M | $16.2M | $17.4M | |
| Beginning Cash (CF) | $1.1M | $134.1K | $1.7M | $2.2M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $921.4K | -$1M | $1.5M | $553.5K | $5.7M | |
| Ending Cash (CF) | $2.1M | -$760.9K | $3.2M | $2.8M | $13.9M | |
| Levered Free Cash Flow | -$4.2M | -$5M | -$5.3M | -$15.6M | -$11.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$525.1K | -$2.8M | -$435.9K | -$616.1K | -$1.9M | |
| Depreciation & Amoritzation | $9.9K | $10.9K | $10.3K | $9.5K | $252.7K | |
| Stock-Based Compensation | -- | $1.9M | $113K | -- | -- | |
| Change in Accounts Receivable | $16.3K | -$85.5K | -$14.5K | -$9.4K | -$16.5K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $221.9K | -$294.1K | -$521.4K | $9.8M | -$8.8M | |
| Capital Expenditures | $909.3K | $1.3M | $155.5K | $10.3M | -$2.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$909.3K | -$1.3M | -$155.5K | -$10.3M | $2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $20K | $233.1K | $32.2K | $925.4K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | $28.3K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $553K | -- | $119.8K | -$907.6K | -- | |
| Cash From Financing | $9.2K | $554.9K | $147.2K | $153.8K | $241.2K | |
| Beginning Cash (CF) | $1.1M | $134.1K | $1.7M | $2.2M | $8M | |
| Foreign Exchange Rate Adjustment | $12.7K | $186.8K | $36K | $28.6K | $214.5K | |
| Additions / Reductions | -$665.5K | -$804K | -$493.8K | -$287.5K | -$5.5M | |
| Ending Cash (CF) | $488.3K | -$483.1K | $1.2M | $2M | $2.7M | |
| Levered Free Cash Flow | -$687.4K | -$1.6M | -$676.9K | -$469.9K | -$6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.7M | -$5M | -$4.4M | -$2.9M | -$3.6M | |
| Depreciation & Amoritzation | $29.3K | $40.7K | $41.1K | $39.9K | $275.1K | |
| Stock-Based Compensation | -- | $2M | $1.3M | -- | -- | |
| Change in Accounts Receivable | -$30.5K | $5.8K | $16.2K | -$32.9K | -$47.1K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.8M | -$1.8M | -$1.7M | $405.5K | -$1.9M | |
| Capital Expenditures | $2.3M | $3.2M | $3.6M | $16M | $10M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.3M | -$3.1M | -$3.5M | -$16M | -$10M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $6.2M | $14.1M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $521.7K | -$688K | -- | |
| Cash From Financing | $5.1M | $3.8M | $6.8M | $16.2M | $17.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $921.4K | -$1M | $1.5M | $553.5K | $5.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4.2M | -$5M | -$5.3M | -$15.6M | -$11.9M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5M | -$4.4M | -$2.9M | -$3.6M | -- | |
| Depreciation & Amoritzation | $40.7K | $41.1K | $40K | $275.1K | -- | |
| Stock-Based Compensation | $2M | $1.3M | -- | -- | -- | |
| Change in Accounts Receivable | $5.8K | $16.2K | -$32.9K | -$47.2K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.8M | -$1.7M | $405.4K | -$1.9M | -- | |
| Capital Expenditures | $3.2M | $3.6M | $16M | $10M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1M | -$3.5M | -$16M | -$10M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $236.5K | $6.2M | $14.1M | $1.8M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $521.7K | -$688K | -- | -- | |
| Cash From Financing | $3.8M | $6.8M | $16.2M | $17.4M | -- | |
| Beginning Cash (CF) | $2.5M | $2.5M | $24.1M | $26.4M | -- | |
| Foreign Exchange Rate Adjustment | $111.9K | $49.8K | $22.2K | $205.3K | -- | |
| Additions / Reductions | -$1M | $1.5M | $553.6K | $5.7M | -- | |
| Ending Cash (CF) | $1.6M | $4.1M | $24.6M | $32.4M | -- | |
| Levered Free Cash Flow | -$5M | -$5.3M | -$15.6M | -$11.9M | -- | |
Get ARS.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARS.CX
Sector
P/E ratio
--
19.88x
PEG ratio
-0.37x
-0.02x
P/B ratio
6.73x
1.85x
Price / LTM sales
--
1.65x
Growth Metrics
ARS.CX
Sector
Revenue growth
--
2.4%
Earnings growth
--
--
Revenue (5-year growth)
--
3.24%
Earnings forecast
--
$0.03
Profitability
ARS.CX
Sector
Profitability FY 2025
-$275.1K
--
Return on invested capital
-9.18%
-9.18%
Return on assets
-8.17%
-10.59%
Return on equity
-26.28%
-9.79%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
ARS.CX
Sector
Total cash
$13.5M
$2.6M
Short term investments
--
$217K
Total assets
$53.9M
$16.7M
Long term debt
$35.3M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
